Translocation Carcinoma: Rare Case

Conclusion & Impact:In thiscase report, we aimed to discuss translocation carcinoma as an important differantial diagnosisin pediatric renal tumours

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:translokasyon karsinomu · pediatrik böbrek tümörü · translocation carcinoma

Abstract

Translocation carcinoma is a recently described tumour which was replaced in the latest WHOclassification. Translocation carcinoma comprises about 1/3 of pediatric renal tumours. In thiscase report, we aimed to discuss translocation carcinoma as an important differantial diagnosisin pediatric renal tumours

Özet

Translokasyon karsinomu, son WHO sınıflamasında yer alan yeni tanımlanmış bir tümördür.Pediatrik böbrek tümörlerinde 1/3 oranında görülür. Bu vaka sunumunda; pediatrik böbrektümörlerinde akılda tutulması gereken bir ayırıcı tanı olan translokasyon karsinomununtartışılması amaçlanmıştır

Keywords

translokasyon karsinomu pediatrik böbrek tümörü translocation carcinoma pediatric renal tumour

🔖

Cite This Article

KADIOĞLU, N., TEKİN, A., BAŞAR, F., AYDIN, H. R., OKTAY, M., ERDEM, H. (2015). Translocation Carcinoma: Rare Case. Düzce Tıp Fakültesi Dergisi, Cilt: 17 - Sayı: 3, 124–125. https://ajindex.com/articles/420247

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Eble JN, Togashi K, Pisani P. Renal carcinomas associated with Xp11.2 translocations / TFE3 gene fusions. Ed: John N. Eble, Guido Sauter, Jonathan I. Epstein, Isabell A. Sesterhenn Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press Lyon, pp: 37-38, 2004
Gregory T. MacLennan, Liang Cheng, Translocation Carcinoma. Ed: David G. Bostwick, Liang Cheng, Urologic Surgical Pathology, pp:101, 2008
Robert O Petersen, Isabell A Sesterhenn, Charles J Davis, Urologic pathology. 3rd ed. Lippincott: Williams and Wilkins,pp: 64, 2008
Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A. Renal cell carcinoma associated with transcription factor E3 expression characteristics, and prognosis.Am J Clin Pathol. 137(5):761- 8, 2012
Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 27(1):113-27, 2014 6. Fall B, Sarr A, Sow Y, Diao B Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement. Afr J Paediatr Surg.;8(3):317-9. 2011
Zhou AG, Owens CL, Cosar EF, Jiang Z. Arch Pathol Lab Med. 137(7):887-93, 2013
Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol.126(3):349- 64, 2006 Perlman EJ. Pediatric Renal Cell Carcinoma. Surg Pathol Clin. 3(3):641-651, 2010
Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.; Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement 22(2), pp: 107–111, 2013
Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, and Stephen M. Rohan Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine. Archives of Pathology & Laboratory Medicine,(37) 4, pp: 467-480, 2013